Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror | BioSpace
Teva to acquire Allergan for $40B
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire
Teva stocks fall after company said named in US price-fixing drug 'cartel' probe | The Times of Israel
Teva recalls US-made drugs following contamination fears - The Boston Globe
Teva stock gains on new growth strategy; Evercore upgrades | Seeking Alpha
Teva Pharmaceutical Stock Could Double | Barron's
Teva shares approach 20-year low amid Moody's warning and other woes | Fierce Pharma
Teva enters opioid settlement agreement with US state Rhode Island
Teva to Launch New Growth Strategy at Investor Day